CHU Amiens
Amiens, 80480, France
Location status: Recruiting
NCT Number: NCT04748796
Several data emphasize the relation between tachycardia (>90/min) and high mortality during septic shock. The investigators previously demonstrated the high mortality associated with hypercontractility, tachycardia and the presence of a left ventricular obstruction. A severe hypovolemia, a hyper adrenergic stimulation or a severe vasoplegia can all explain this relation between tachycardia, hypercontractility and the mortality during septic shock.
Landiolol is another short-term acting beta-blocker with a half-life of 4 minutes without any beta 2 activity or membrane stabilizing effect. The landiolol has been used in critically ill patients to control supraventricular tachycardia but not in this context of tachycardia and septic shock. The investigators hypothesize that landiolol by reducing the heart rate may improve the survival of patients treated for a septic shock and presenting with an hypercontractility state.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Phase 3
Amiens, 80480, France
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Full echocardiography will be performed at baseline and during the follow-up at H1, H3, H6 and H12.
Patients randomized to the experimental group will be treated according to the standard of care plus for 2 days with landiolol IV started at a dose of 1 microgram/kg/min and progressively increased every 10 minutes to a maximum of 40 micrograms/kg/min.
Time frame: day 28
Interested in participating?
Request InfoCentre Hospitalier Universitaire, Amiens
Other
Comparison of Landiolol Versus Standard of Care for Prevention of Mortality in Patients Hospitalized for a Septic Shock With Hypercontractility: an Open Label Prospective Randomized Study
Acronym: HyperBetashock
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02188888
Arrhythmias, Cardiac, Cardiac Conduction System Disease
Rome, Italy
View Trial DetailsNCT01231698
Arrhythmias, Cardiac, Cardiac Conduction System Disease
Rome, Italy
View Trial DetailsNCT07124741
Infections, Inflammation
Antalya, Turkey (Türkiye)
View Trial DetailsNCT04494074
Body Temperature Changes, Fever
Amiens, France
View Trial Details